A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting with acute coronary Syndrome (IMProved Reduction of Outco...

Klinische Forschung - 24.01.2006 - 18.08.2015

Abgeschlossen

Projektleitung: Rickli Hans, Gemperle Michaela
Mitarbeiter/innen: Bluzaite Ina